Drug Manufacturers - Major
(ABT) Abbott Laboratories - Worldwide sales jumped 17.6% on a year-over-year basis
Abbott Laboratories (ABT) saw all 12 covering analysts boost full-year earnings estimates. Forecasts of $3.32 per share were increased from last month’s $3.27. Company Description Abbott is a global, broad-based health care company that develops, manufactures and markets pharmaceuticals...
6Nov2008 | Shawn | 0 comments | Continued(ABT) - Abbott Laboratories - Worldwide sales jumped 17.6% on a year-over-year basis
Abbott Laboratories (ABT) recently posted strong results for the third quarter. Earnings per share of 79 cents surpassed the year-prior 67 cents and exceeded the consensus estimate by 3%. Worldwide sales jumped 17.6% on a year-over-year basis. The company hiked its full-year...
25Oct2008 | Shawn | 0 comments | Continued(ABT) - Abbott Laboratories - Worldwide sales jumped 17.6% on a year-over-year basis
Abbott Laboratories (ABT) recently posted strong results for the third quarter. Earnings per share of 79 cents surpassed the year-prior 67 cents and exceeded the consensus estimate by 3%. Worldwide sales jumped 17.6% on a year-over-year basis. The company hiked its full-year...
24Oct2008 | Shawn | 0 comments | Continued(ABT) - Abbott Laboratories - Worldwide sales jumped 17.6% on a year-over-year basis
Abbott Laboratories (ABT) recently posted strong results for the third quarter. Earnings per share of 79 cents surpassed the year-prior 67 cents and exceeded the consensus estimate by 3%. Worldwide sales jumped 17.6% on a year-over-year basis. The company hiked its full-year...
22Oct2008 | Shawn | 0 comments | Continued(ABT) - Abbott Laboratories - solid return on equityof 27%, which tops the industry average of -13%
Abbott Laboratories (ABT), which is trading near a 52-week high, announced stellar results for the second quarter and boosted its full-year 2008 guidance in mid-July. Wall Street earnings forecasts have moved higher since. Full-year 2008 estimates of $3.27 per share advanced...
4Sep2008 | Shawn | 0 comments | Continued(ABT) - Abbott Laboratories - solid return on equityof 27%, which tops the industry average of -13%
Abbott Laboratories (ABT), which is trading near a 52-week high, announced stellar results for the second quarter and boosted its full-year 2008 guidance in mid-July. Wall Street earnings forecasts have moved higher since. Full-year 2008 estimates of $3.27 per share advanced...
21Aug2008 | Shawn | 0 comments | Continued(ABT) - Abbott Laboratories - dividend yield of 2.5% - most companies within its industry group offer no dividend
Abbott Laboratories (ABT) recently released stellar results for the second quarter and hiked its full-year 2008 guidance. Nearly all covering analysts responded by increasing their full-year estimates. The company offers ROE of 28%, above the industry average of 27%. In early...
24Jul2008 | Shawn | 0 comments | Continued